Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00980707 · ClinicalTrials.gov registry record · Phase 4
Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma
A Phase 4 study, sponsored by Associated Scientists to Help Minimize Allergies.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT00980707 is a Phase 4 study that has completed, run by Associated Scientists to Help Minimize Allergies. The registered enrollment target is 10 participants.
The verdict
NCT00980707, a Phase 4 study, has completed, sponsored by Associated Scientists to Help Minimize Allergies.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the role of versican and hyaluronan measurements in induced sputum as biomarkers of asthma. Enroll 10 subjects with mild persistent asthma who are not receiving treatment with a controller therapy.
Interventions
- DRUG Inhaled corticosteroid (fluticasone)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-08 |
| Est. Completion | 2010-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00980707
The ClinicalTrials.gov registry entry for NCT00980707 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Associated Scientists to Help Minimize Allergies, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Inhaled corticosteroid (fluticasone) is the first listed.
NCT00980707 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00980707 about?
NCT00980707 is a clinical study titled "Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma". The purpose of this study is to determine the role of versican and hyaluronan measurements in induced sputum as biomarkers of asthma. Enroll 10 subjects with mild persistent asthma who are not receiving treatment with a controller therapy.
What is the current status of trial NCT00980707?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2009-08. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00980707?
The interventions under investigation include: Inhaled corticosteroid (fluticasone) (DRUG).
Who is sponsoring clinical trial NCT00980707?
This trial is sponsored by Associated Scientists to Help Minimize Allergies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.